Skip to main content
. Author manuscript; available in PMC: 2011 Aug 19.
Published in final edited form as: J Med Genet. 2009 Nov 12;47(5):332–341. doi: 10.1136/jmg.2009.073015

Figure 1.

Figure 1

Distribution of clinical indications at the time of referral to array comparative genomic hybridisation (aCGH) testing among patients with 16p11.2 deletion and duplication. DYSMOR, dysmorphism; FTT, failure to thrive; MCA, congenital anomalies; MR/DD, mental retardation/developmental delay; SZ, seizures.